Sam Altman’s longevity startup is upping the dose in an Alzheimer’s drug trial after a lackluster first round
The Sam Altman-funded longevity startup Retro Biosciences is testing a longevity pill that the…
The Sam Altman-funded longevity startup Retro Biosciences is testing a longevity pill that the…
